Utilizing coronary physiology to guide acute coronary syndrome management: are we there yet?

References

• 1. Neumann FJ, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur. Heart J. 40(2), 87–165 (2019).
  MedlineGoogle Scholar
• 2. Dall'Armellina E, Karamitsos TD, Neubauer S, Choudhury RP. CMR for characterization of the myocardium in acute coronary syndromes. Nat. Rev. Cardiol. 7(11), 624–636 (2010).
  MedlineGoogle Scholar
• 3. Betgem RP, de Waard GA, Nijveldt R, Beek AM, Escaned J, van Royen N. Intramyocardial haemorrhage after acute myocardial infarction. Nat. Rev. Cardiol. 12(3), 156–167 (2015).
  MedlineGoogle Scholar
• 4. De Maria GL, Fahrni G, Banning AP. The temporal recovery of fractional flow reserve, coronary flow reserve and index of microcirculatory resistance following myocardial infarction. Curr. Opin. Cardiol. 30(6), 663–670 (2015).
  MedlineGoogle Scholar
• 5. Papapostolou S, Andrianopoulos N, Duffy SJ et al. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry. EuroIntervention 14(2), 185–193 (2018).
  MedlineGoogle Scholar
• 6. Smits PC, Abdel-Wahab M, Neumann FJ et al. Compare-acute I. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N. Engl. J. Med. 376, 1234–1244 (2017).
  MedlineGoogle Scholar
• 7. Cuculi F, De Maria GL, Meier P et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 64(18), 1894–1904 (2014).
  MedlineGoogle Scholar
• 8. Kelbaek H, Hofsten DE, Kober L et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet 387(10034), 2199–2206 (2016).
  MedlineGoogle Scholar
• 9. De Maria GL, Cuculi F, Patel N et al. How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction? Eur. Heart J. 36(45), 3165–3177 (2015).
  MedlineGoogle Scholar
• 10. Hoebers LP, Vis MM, Claessen BE et al. The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. Eur. J. Heart Fail. 15(4), 425–432 (2013).
  MedlineGoogle Scholar
• 11. Ntalianis A, Sels JW, Davidavicius G et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc. Interv. 3(12), 1274–1281 (2010).
  MedlineGoogle Scholar
• 12. Musto C, De Felice F, Rigattieri S et al. Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: the WAVE study. Am. Heart J. 193, 63–69 (2017).
  MedlineGoogle Scholar
• 13. Thim T, Gotberg M, Frobert O et al. Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc. Interv. 10(24), 2528–2535 (2017).
  MedlineGoogle Scholar
• 14. Engstrom T, Kelbaek H, Helqvist S et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3–PRIMULTI): an open-label, randomised controlled trial. Lancet 386(9994), 665–671 (2015).
  MedlineGoogle Scholar
• 15. Wang LJ, Han S, Zhang XH, Jin YZ. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review. BMC Cardiovasc. Disord. 19(1), 49 (2019).
  MedlineGoogle Scholar
• 16. Sels JW, Tonino PA, Siebert U et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc. Interv. 4(11), 1183–1189 (2011).
  MedlineGoogle Scholar
• 17. Layland J, Oldroyd KG, Curzen N et al. Fractional flow reserve vs angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur. Heart J. 36(2), 100–111 (2015).
  MedlineGoogle Scholar
• 18. Masrani Mehta S, Depta JP, Novak E et al. Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome. J. Am. Heart Assoc. 4(8), e002172 (2015).
  MedlineGoogle Scholar